CST3 and atherosclerosis: We have previously identified novel interactions between eQTL and clinical traits in the DO, including atherosclerosis (Smallwood et al. 2014), the atherosclerosis-associated plasma metabolite trimethylamine N-oxide (Coffey et al. 2019), and plasma cystatin C (Huda et al. 2020).